Skip to main content

Table 1 Desired properties for drug candidate taken for evaluation in formal animal toxicity studies.

From: Requirements for a lead compound to become a clinical candidate

Properties

Details

Chemical properties

Stable molecule

 

Nonproblematic synthesis with potential for scale-up

Pharmacological properties

Selective high-affinity binding to target binding site

 

Selective and potent functional effect on target receptor molecule in vitro

 

Effectiveness in animal model of targeted human indication

Pharmacokinetics

Adequate bioavailability for selected route of administration

 

Adequate half-life and biodistribution for intended use

Safety and toxicity

Satisfactory profile for inhibition and induction of cytochrome P450 enzymes

 

Absence of obvious cardiac toxicity (hERG binding)

 

Absence of obvious toxicity in animal studies